4//SEC Filing
Cieplinska Agnieszka 4
Accession 0001104659-20-080019
CIK 0001235010other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:15 PM ET
Size
8.7 KB
Accession
0001104659-20-080019
Insider Transaction Report
Form 4
Cieplinska Agnieszka
Chief Accounting Officer (PAO)
Transactions
- Award
Restricted Stock Units
2020-06-29+3,150→ 9,450 total→ Common Stock (3,150 underlying) - Sale
Common Stock
2020-06-30$35.11/sh−947$33,249→ 7,574 total - Award
Common Stock
2020-06-29+3,150→ 8,521 total
Footnotes (4)
- [F1]Shares received pursuant to settlement of Performance Stock Units that were granted on April 12,2019.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- [F4]Subject to the officer's continued employment with the company, 3,150 Restricted Stock Units will vest on June 29, 2021.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001798748
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 9:15 PM ET
- Size
- 8.7 KB